Sign in
CompletedNo phase

Screen, Treat and Retain People With Primary Meth Use Disorder at MMT Clinics

Key facts

Who runs it
Hanoi Medical University
Where
Vietnam1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
24 Feb 2025
Ended
30 Sept 2025
Type of study
Interventional, 3 groups
Treatments tested
  • Contingency management for substance use
  • Contingency management for attendance
  • Group-based Matrix counseling
  • Individual-based Matrix counseling
Record updated
16 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age: ≥ 18
  • ASSIST ≥ 10 OR urine drug screen positive with meth
  • Urine drug screen negative with opioid and methadone
  • Willing to participate in study interventions at selected MMT clinics

Who cannot take part

  • Unable to read and write Vietnamese
  • Being incapable of understanding questions and research processes

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is built upon the STAR-OM study (R01 DA050486) to assess if providing psycho-behavioral interventions and medications for people with primary methamphetamine use disorder (MUD) and without opioid use disorder (OUD) at methadone clinics is feasible and acceptable. In Vietnam and many U.S. settings, clinics providing medication for OUD (especially methadone clinics) are the only viable option for evidence-based addiction treatment. Importantly, many of these clinics are at primary care level and therefore accessible to people with primary MUD, who are in dire need for effective treatment. Furthermore, providers in methadone clinics are capable of conducting psycho-behavioral interventions, which remain the first line of treatment for MUD, and prescribing medications should these medications become available and approved by authorities. It remains unknown, however, if methadone clinics could serve as treatment facilities for those with primary MUD. This Supplement to the STAR-OM study will 1) assess the feasibility and acceptability of three recruitment strategies to enroll people with MUD and without OUD in MUD treatment at methadone clinics and 2) explore the feasibility and acceptability of providing psycho-behavioral interventions as well as challenges in providing medications at methadone clinics for people with MUD and without OUD. In Aim 1, the study will screen 600 people with primary MUD recruited through three strategies (peer outreach, snowballing and social media) over 3 months to enroll 60 people with MUD and without OUD into the study interventions. Participants will be screened at MMT clinics for meth use and readiness for MUD intervention. The study team will monitor recruitment rate for each strategy to assess feasibility. Acceptability will be assessed through focus group discussions with people who support recruitment (N=2 focus group with 12-16 participants), in-depth interviews with individuals eligible for enrollment and agree or decline to participate in the study interventions (N=15, 5 per recruitment strategy). In Aim 2, consenting participants will be randomized 1:1:1 into three arms of interventions over 12 weeks: (1) contingency management only; (2) group-based Matrix plus contingency management; and (3) individual-based Matrix plus contingency management. All participants will be required to provide urine samples randomly once a week. The investigators will monitor participation and retention rate in each treatment arm and completion of urine drug screens to assess feasibility. Acceptability will be assessed through post-intervention in-depth interviews with 15 participants, focus groups with methadone providers who deliver behavioral interventions (N = 1 focus group with 6-8 participants), and in-depth interviews with policy makers at national and city levels (N=5). In addition, participants will be asked in these interviews and focus groups about the challenges and facilitators of providing medications for treatment of MUD at MMT clinics should they become available. Findings from this Supplement will be used to prepare for a larger trial to assess effectiveness of implementing psycho-behavioral interventions for people with primary MUD and without OUD at methadone clinics.

The 3 groups in the trial

  • Contingency management for Substance useTreatment being tested

    Participants receive contingency management for their abstinence over 12 weeks

  • Group-based Matrix plus contingency managementTreatment being tested

    Participants receive group-based Matrix counseling and contingency management for their attendance in group counseling sessions

    Treatment: Contingency management for attendance and Group-based Matrix counseling

  • Individual-based Matrix plus contingency managementTreatment being tested

    Participants receive individual-based Matrix counseling and contingency management for their attendance in individual counseling sessions

    Treatment: Contingency management for attendance and Individual-based Matrix counseling

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 September 2026